Acciones Biotie Therapies Corp OTC Markets

Acciones

Precio de cierre OTC Markets Otros sitios de cotización			Varia. Cinco días.	Varia. 1 de enero.
- ^USD	-.--%		-.--%	-.--%

Duración

Período

Estilo

Biotie Therapies : ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST	30/09/16
Biotie Therapies : ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED	26/09/16
Biotie: BTT1023 receives Orphan Drug Designation in the United States	26/08/16
Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.	25/08/16
Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI	18/08/16

Directores	Puesto	Edad	Desde
Antero Kallio CEO	Chief Executive Officer	64	01/06/05

Administradores	Puesto	Edad	Desde
Ronald Cohen CHM	Chairman	68	01/05/16
Jane Wasman BRD	Director/Board Member	67	01/05/16
Andrew Hindman BRD	Director/Board Member	51	01/12/16

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+5,33 %	111 mil M
REGENERON PHARMACEUTICALS, INC.	+12,11 %	106 mil M
BIONTECH SE	-12,56 %	22,24 mil M
ARGENX SE	-3,70 %	21,25 mil M
GENMAB A/S	-6,03 %	18,97 mil M
WUXI APPTEC CO., LTD.	-35,21 %	18,52 mil M
BEIGENE, LTD.	-10,86 %	16,81 mil M
NEUROCRINE BIOSCIENCES, INC.	+5,10 %	13,94 mil M
SAREPTA THERAPEUTICS, INC.	+37,57 %	12,54 mil M